Sector Expert: Amit Tandon

SeeThruEquity



Recent Quotes

"We were enthused by 2Q16 results and outlook at INNV, which clearly showed the company is in growth mode."

— Amit Tandon, SeeThruEquity (8/15/16)
more >

"INNV recently completed the acquisition of Beyond Human™, which has expanded its pipeline to include 13 commercialized products and three pipeline products, and has several upcoming key milestones on the horizon."

— Amit Tandon, SeeThruEquity (5/23/16)
more >

"With the acquisition of assets of Beyond Human, INNV now has 13 commercial products and 3 pipeline products targeting a $3 billion market opportunity in men’s and women's health and vitality and respiratory disease."

— Amit Tandon, SeeThruEquity (4/19/16)
more >

"AEMD's uplisting is a significant accomplishment that will positively affect liquidity and visibility."

— Amit Tandon, SeeThruEquity (7/8/15)
more >

"AEMD has increased its net worth by approximately $16M since the end of FY/14."

— Amit Tandon, SeeThruEquity (2/13/15)
more >



Due to permission requirements, not all quotes are shown.